Skip to content
10-K

Annual Report

ACRO BIOMEDICAL CO., LTD. ACBM

0001640334-25-001245

← back to feed
Filed
Jul 18, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2023 · Jul 18, 2025 60.04M sh
Gross Profit FY 2023 · Dec 31, 2023 $0
Gross Profit FY 2023 · Dec 31, 2022 $140.5K
Cost Of Revenue FY 2023 · Dec 31, 2023 $0
Cost Of Revenue FY 2023 · Dec 31, 2022 $518K
Shares Diluted FY 2023 · Dec 31, 2022 60.04M sh
Operating Cash Flow FY 2023 · Dec 31, 2022 −$147.48K
Current Liabilities FY 2023 · Dec 31, 2022 $201.12K
Total Liabilities FY 2023 · Dec 31, 2022 $201.12K
Current Assets FY 2023 · Dec 31, 2022 $657.54K
Total Assets FY 2023 · Dec 31, 2022 $687.49K
Eps Diluted FY 2023 · Dec 31, 2022 −$0.26
Sga Expense FY 2023 · Dec 31, 2022 $5.93M
Rd Expense FY 2023 · Dec 31, 2022 $10.08M
Net Income FY 2023 · Dec 31, 2022 −$15.87M
Operating Income FY 2023 · Dec 31, 2022 −$15.87M
Revenue FY 2023 · Dec 31, 2022 $658.5K
Stockholders Equity FY 2023 · Dec 31, 2021 $643.71K